Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Bawat – Presentation of Q4 2022 interim report

By Michael FriisHead of Equities
Bawat Water Technologies
Today, Bawat announced its Q4 2022 report. We have interviewed Bawat’s CEO Marcus Peter Hummer to get an update on the results and hear more about the expectations for 2023.

Looking at highlights from the report and the interview, Bawat has already announced its 2022 order intake in mid-January of SEK 18.1m (full-year guidance was SEK 35-50m). Delays in decision-making with two large clients implied that Bawat reached an order intake of SEK 1.2m in Q4 2022. However, Bawat now reports that a large order for a mobile unit has been confirmed in February 2023, and the second large order for mobile units is still in commercial negotiations.

Focusing on the market, quoting activity remains at a high level and reached a record level of more than SEK 75m in Q4 2022. Bawat still sees a higher interest from potential customers, despite that the company experiences longer sales periods than expected from initial contact to the decision of an actual order on its Mobile Solutions.

For the full year 2023, Bawat’s guidance is an order intake in the range of SEK 40-60m. EBITDA is estimated to reach break-even in H2 2024.

Read the full report here: https://view.news.eu.nasdaq.com/view?id=bc5dfb511fc1f1792e4a39310f2945956&lang=en

Disclaimer: HC Andersen Capital receives payment from Bawat for a DigitalIR/Corporate Visibility agreement. /Michael Friis 17:30, 21 February 2023.

Recent videos

A sit-down with CEO Remco Westermann
12.12.2025 klo 10.09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
11.12.2025 klo 12.00 Aiforia Technologies
Endomines as an Investment | Investor Day Nov. 24, 2025
10.12.2025 klo 13.30 Endomines Finland
Clas Ohlson, Audiocast, Q2'25
10.12.2025 klo 10.00 Clas Ohlson
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
09.12.2025 klo 23.11 Herantis Pharma
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.